# NCI Awards Envisagenics $2M+ AI Grant

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded Envisagenics a two-year SBIR Direct to Phase II grant worth more than **$2 million** on October 13, 2026. The funding will advance SpliceDisco, a machine-learning capability within the company’s SpliceCore platform, to identify and validate cancer-specific therapeutic targets through RNA splicing analysis. The award supports Envisagenics’ oncology development and could create collaboration opportunities in oncology research, transcriptomics, and experimental validation; the signals provide no solicitation details or procurement contact for the grant opportunity.

- The award is a concrete example of federal SBIR funding for AI-enabled precision oncology and RNA splicing research.
- Research organizations and contractors with oncology, transcriptomics, or experimental-validation capabilities may find potential collaboration opportunities with Envisagenics, though no open solicitation is identified.
- Companies pursuing similar federal research funding can use this award as an indication of NCI interest in machine-learning approaches to cancer-target discovery.

**Jurisdictions:** federal
**Industries:** Healthcare, Information Technology
**Topics:** Artificial Intelligence, Grants & Funding
**Published:** October 14, 2026

### Government Entities
- National Cancer Institute (NCI)
- National Institutes of Health (NIH)

### Vendors
- Envisagenics, Inc. (awardee)

### Key Quotes
> an important milestone in our mission to unlock the therapeutic potential of RNA splicing biology in oncology.
> — Maria Luisa Pineda, Chief Executive Officer

### Sources
- [ Envisagenics Awarded $2M+ NCI SBIR Grant to Expand AI-Driven RNA Splicing Analysis Capabilities Across Oncology Portfolio

 | The Manila Times ](https://www.manilatimes.net/2026/10/13/tmt-newswire/globenewswire/envisagenics-awarded-2m-nci-sbir-grant-to-expand-ai-driven-rna-splicing-analysis-capabilities-across-oncology-portfolio/2444524) - The Manila Times
- [Envisagenics lands $2M NCI grant to expand AI splicing platform | Dealroom.co](https://app.dealroom.co/news/note/envisagenics-lands-2m-nci-grant-to-expand-ai-splicing-platform) - Dealroom